The role of naloxone in poisoning

DXM FAQ 1997: selective audit by topic

What clinical guidance says about naloxone and the limits of its effects.

Naloxone: a limited clinical role

Clinical guidance allows consideration of naloxone in marked sedation or coma, particularly with respiratory depression. The overall response in DXM intoxication remains unpredictable.

Corrected

According to the 2026 audit · edition

Evidence and limitations

What was examined: Chyka’s consensus guideline assigns this recommendation Grade C. It addresses poisoning management and patient referral.

Limits of the conclusion: Use belongs within medical care. This section explains the evidence without providing a self-treatment protocol.

Sources: Chyka — clinical poisoning guideline

Historical paraphrase · FAQ 4.0 · 1997 · §6.10 The FAQ presents intravenous naloxone as an antidote for DXM poisoning.

This claim in the 2026 audit · Erowid archive (HTML 4.0-Y.1) · §6.10 · How Toxic is DXM, and What is the Lethal Dose?

Sources for this topic
  1. Chyka — clinical poisoning guideline — PubMed abstract

All update topics · Review coverage

Reference

Open the source and related combinations →